SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought together a wide and diverse community involved in tuberculosis vaccine research and development to discuss the current status of, and future directions for this critical effort. This paper summarizes the sessions on TB Vaccines in Clinical Development, and Clinical Research: Data and Findings. Summaries of all sessions from the 4th Global Forum are compiled in a special supplement of Tuberculosis. [August 2016, Vol 99, Supp S1, S1–S30]
The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB...
Tuberculosis continues to kill 1.4 million people annually. During the past 5 years, an alarming inc...
The quest for a vaccine that could have a major impact in reducing the current global burden of TB d...
The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought t...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
In May 2005, the TB Vaccine Initiative of the World Health Organization (WHO) Initiative for Vaccine...
In September 2003, Montreal hosted the first international conference on "TB Vaccines for the World"...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
SummaryThe quest for a vaccine that could have a major impact in reducing the current global burden ...
AbstractTB is now the single pathogen that causes the greatest mortality in the world, at over 1.6 m...
At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more t...
The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB...
Tuberculosis continues to kill 1.4 million people annually. During the past 5 years, an alarming inc...
The quest for a vaccine that could have a major impact in reducing the current global burden of TB d...
The 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, brought t...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
SummaryThe 4th Global Forum on TB Vaccines, convened in Shanghai, China, from 21 – 24 April 2015, br...
In May 2005, the TB Vaccine Initiative of the World Health Organization (WHO) Initiative for Vaccine...
In September 2003, Montreal hosted the first international conference on "TB Vaccines for the World"...
One of the aims of the World Health Organisation (WHO) Millennium Development Goals (MDG) is to redu...
SummaryThe quest for a vaccine that could have a major impact in reducing the current global burden ...
AbstractTB is now the single pathogen that causes the greatest mortality in the world, at over 1.6 m...
At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more t...
The Bacille Calmette Guerin (BCG) vaccine can provide decades of protection against tuberculosis (TB...
Tuberculosis continues to kill 1.4 million people annually. During the past 5 years, an alarming inc...
The quest for a vaccine that could have a major impact in reducing the current global burden of TB d...